Revolution Medicines (RVMD) EBT Margin Growth (3y) (2022 - 2023)

Revolution Medicines (RVMD) EBT Margin Growth (3y) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,237.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 441.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -408.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 363.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 7,297.00

Historic Data

Download Data
DateValue
Dec 31, 2023 -2.13 Mn
Jun 30, 2023 -229,850.00
Mar 31, 2023 -79,599.00
Dec 31, 2022 -21,248.00
Sep 30, 2022 -209,137.00
Jun 30, 2022 -58,919.00
Mar 31, 2022 -68,377.00